Sumitomo Pharma Co., Ltd. Logo

Sumitomo Pharma Co., Ltd.

4506 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
大阪市中央区道修町2丁目6番8号
Sector:
Health Care
Industry:
Pharmaceuticals

Description

Sumitomo Pharma Co., Ltd. is a leading Japanese pharmaceutical company dedicated to improving global healthcare through innovative research and development. With a focus on oncology, psychiatry, and neurology, the company aspires to enhance its global presence by leveraging its robust R&D capabilities, skilled workforce, and diverse business platforms. By FY2033, Sumitomo Pharma aims to effectively transform its "value creation cycle," translating cutting-edge science into practical healthcare solutions. The company's commitment to sustainability and employee development fosters a dynamic corporate culture, promoting diversity and professional growth. With strategic operations in Japan and the U.S., Sumitomo Pharma is poised to meet the evolving needs of patients worldwide.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-27 09:05
Inside Information Statement
臨時報告書
Japanese 29.6 KB
2025-06-26 09:39
Regulatory News Service
確認書
Japanese 8.7 KB
2025-06-26 09:36
Internal Control over Financial Reporting
内部統制報告書-第205期(2024/04/01-2025/03/31)
Japanese 24.0 KB
2025-06-26 09:31
Annual Report
有価証券報告書-第205期(2024/04/01-2025/03/31)
Japanese 2.1 MB
2025-05-30 09:41
Regulatory News Service
訂正臨時報告書
Japanese 40.7 KB
2025-05-14 09:18
Regulatory News Service
訂正臨時報告書
Japanese 36.6 KB
2025-04-28 10:06
Regulatory News Service
訂正臨時報告書
Japanese 24.3 KB
2025-04-28 10:03
Inside Information Statement
臨時報告書
Japanese 19.0 KB
2025-04-03 09:39
Inside Information Statement
臨時報告書
Japanese 41.7 KB
2025-01-31 08:11
Inside Information Statement
臨時報告書
Japanese 18.7 KB
2024-12-19 07:19
Inside Information Statement
臨時報告書
Japanese 19.2 KB
2024-11-01 03:30
Regulatory News Service
確認書
Japanese 8.7 KB
2024-11-01 03:26
Interim Report
半期報告書-第205期(2024/04/01-2025/03/31)
Japanese 334.4 KB
2024-10-30 07:42
Inside Information Statement
臨時報告書
Japanese 18.6 KB
2024-07-31 08:40
Inside Information Statement
臨時報告書
Japanese 18.7 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
D.Western Therapeutics Institute, Inc. Logo D.Western Therapeutics Institute, Inc. Japan 4576
EARNZ PLC Logo EARNZ PLC United Kingdom EARN
Eevia Health Plc Logo Eevia Health Plc Finland EEVIA
Egetis Therapeutics Logo Egetis Therapeutics Sweden EGTX
EIKEN CHEMICAL CO.,LTD. Logo EIKEN CHEMICAL CO.,LTD. Japan 4549
Eisai Co., Ltd. Logo Eisai Co., Ltd. Japan 4523
ELARIS AG Logo ELARIS AG Germany ELS
Enervit Logo Enervit Italy ENV
Enorama Pharma AB Logo Enorama Pharma AB Sweden ERMA
Enzymatica AB Logo Enzymatica AB Sweden ENZY